These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 22398805)

  • 1. Molecular marker analyses from the SATURN trial.
    Brugger W
    Clin Adv Hematol Oncol; 2012 Jan; 10(1):33-4. PubMed ID: 22398805
    [No Abstract]   [Full Text] [Related]  

  • 2. Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer.
    Cho WC
    Expert Rev Mol Diagn; 2011 Nov; 11(8):763-6. PubMed ID: 22022936
    [No Abstract]   [Full Text] [Related]  

  • 3. EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.
    da Cunha Santos G; Saieg MA; Geddie W; Leighl N
    Cancer Cytopathol; 2011 Apr; 119(2):80-91. PubMed ID: 21400669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray.
    Ye Y; Wang D; Su C; Rong T; Guo A
    Genet Mol Res; 2009 Dec; 8(4):1509-18. PubMed ID: 20082263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic immune markers in non-small cell lung cancer.
    Suzuki K; Kachala SS; Kadota K; Shen R; Mo Q; Beer DG; Rusch VW; Travis WD; Adusumilli PS
    Clin Cancer Res; 2011 Aug; 17(16):5247-56. PubMed ID: 21659461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.
    Shepherd FA; Tsao MS
    J Clin Oncol; 2010 Feb; 28(6):903-5. PubMed ID: 20100955
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between hormone receptor expression and epidermal growth factor receptor mutation in patients operated on for non-small cell lung cancer.
    Sun HB; Zheng Y; Ou W; Fang Q; Li P; Ye X; Zhang BB; Yang H; Wang SY
    Ann Thorac Surg; 2011 May; 91(5):1562-7. PubMed ID: 21524465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
    Dacic S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?
    Dziadziuszko R; Hirsch FR; Varella-Garcia M; Bunn PA
    Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4409s-4415s. PubMed ID: 16857819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on epidermal growth factor receptor mutations in non-small cell lung cancer.
    Riely GJ; Politi KA; Miller VA; Pao W
    Clin Cancer Res; 2006 Dec; 12(24):7232-41. PubMed ID: 17189394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic tumor markers in non-small cell lung cancer.
    Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
    Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in research of molecular imaging of epidermal growth factor receptor in non-small cell lung cancer].
    Yu JM; Liu NB
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):81-4. PubMed ID: 19538879
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non-small-cell lung carcinoma.
    Kim JM; Kang DW; Long LZ; Huang SM; Yeo MK; Yi ES; Kim KH
    Hum Pathol; 2011 Mar; 42(3):315-23. PubMed ID: 21190720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in clonality as a tool for differential diagnosis of primary versus secondary lung neoplasms.
    Leuzzi G; Cesario A; Vita ML; Parisi AM; Petrone G; Martini M; Rindi G; Granone P
    J Thorac Oncol; 2012 May; 7(5):934-6. PubMed ID: 22722795
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of molecular pathology on the clinical management of lung cancer.
    Brambilla E; Brambilla C; Lantuejoul S
    Respiration; 2005; 72(3):229-32. PubMed ID: 15942289
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarker testing in non-small cell lung cancer: a clinician's perspective.
    Bernicker E
    Arch Pathol Lab Med; 2015 Apr; 139(4):448-50. PubMed ID: 25166873
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour evolution: clonal ancestry in lung cancer.
    Alderton GK
    Nat Rev Cancer; 2014 Dec; 14(12):763. PubMed ID: 25568921
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular Marker Testing in Curable Non-Small Cell Lung Cancer-Practice Necessarily Precedes Data.
    Aggarwal C; West HJ
    JAMA Oncol; 2023 Jun; 9(6):758-760. PubMed ID: 37052928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.